Skip to main content
Erschienen in: Medical Oncology 1/2011

01.12.2011 | Original Paper

Development of Marjolin’s ulcer within one month of burn injury with synchronous primary lung squamous cell carcinoma in an elderly patient: report of a case with allelotyping

verfasst von: Adam N. Wooldridge, Michael J. Griesser, Thomas Scharschmidt, O. Hans Iwenofu

Erschienen in: Medical Oncology | Sonderheft 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Marjolin’s ulcer defines the occurrence of malignancy, usually squamous cell carcinoma, in the setting of a post-traumatic scar often following thermal injury. The latency period from the time of injury to the onset of malignant transformation averages 30 years with the earliest documented incidence occurring 6 weeks after injury. In addition, the occurrence of multiple primary malignancies is a rare event. To our knowledge, we report the first case in the literature of a well-differentiated squamous cell carcinoma developing within 1 month of thermal injury to an elderly patient’s right index finger with an incidental synchronous primary lung moderately differentiated squamous cell carcinoma that was morphologically and genetically different as confirmed by allelotyping. There is scant precedent literature on acute Marjolin’s ulcers, and the most acute cases have arisen 6 weeks post-burn. There is also little published literature on the incidence of multiple primary malignancies. The quoted incidence of this event is <1%. Clinicians should be aware of the possibility of malignant transformation at the site of prior thermal injury. Biopsy remains the gold standard for diagnosis for Marjolin’s ulcer. MRI is the most important diagnostic imaging tool because it will demonstrate the margins and extent of the lesion. Due to the aggressive nature of Marjolin’s ulcer, treatment is usually surgical and dependent upon grading. When multiple lesions are detected after staging of a presumed neoplasm, the possibility of multiple primary maligancies should be considered. Allelotyping is a process that can be utilized to determine if multiple masses are related.
Literatur
1.
2.
Zurück zum Zitat Copcu E. Marjolin’s ulcer: a preventable complication of burns? Plast Reconstr Surg. 2009;124(1):156e–64e.PubMedCrossRef Copcu E. Marjolin’s ulcer: a preventable complication of burns? Plast Reconstr Surg. 2009;124(1):156e–64e.PubMedCrossRef
3.
Zurück zum Zitat Giblin T, Pickrell K, Pitts W, Armstrong D. Malignant degeneration in burn scars: Marjolin’s ulcer. Ann Surg. 1965;162:291–7.PubMedCrossRef Giblin T, Pickrell K, Pitts W, Armstrong D. Malignant degeneration in burn scars: Marjolin’s ulcer. Ann Surg. 1965;162:291–7.PubMedCrossRef
4.
Zurück zum Zitat Kowal-Vern A, Criswell BK. Burn scar neoplasms: a literature review and statistical analysis. Burns. 2005;31(4):403–13.PubMedCrossRef Kowal-Vern A, Criswell BK. Burn scar neoplasms: a literature review and statistical analysis. Burns. 2005;31(4):403–13.PubMedCrossRef
5.
Zurück zum Zitat Ogawa B, Chen M, Margolis J, Schiller FJ, Schnall SB. Marjolin’s ulcer arising at the elbow: a case report and literature review. Hand (N Y). 2006;1(2):89–93. Ogawa B, Chen M, Margolis J, Schiller FJ, Schnall SB. Marjolin’s ulcer arising at the elbow: a case report and literature review. Hand (N Y). 2006;1(2):89–93.
6.
Zurück zum Zitat Cruickshank AH, McConnell EM, Miller DG. Malignancy in scars, chronic ulcers, and sinuses. J Clin Pathol. 1963;16:573–80.PubMedCrossRef Cruickshank AH, McConnell EM, Miller DG. Malignancy in scars, chronic ulcers, and sinuses. J Clin Pathol. 1963;16:573–80.PubMedCrossRef
7.
Zurück zum Zitat Steffen C. Marjolin’s ulcer. Report of two cases and evidence that Marjolin did not describe cancer arising in scars of burns. Am J Dermatopathol. 1984;6(2):187–93.PubMedCrossRef Steffen C. Marjolin’s ulcer. Report of two cases and evidence that Marjolin did not describe cancer arising in scars of burns. Am J Dermatopathol. 1984;6(2):187–93.PubMedCrossRef
8.
Zurück zum Zitat Cruickshank AH, Gaskell E. Jean-Nicolas Marjolin: destined to be forgotten? Med Hist. 1963;7:383–4.PubMed Cruickshank AH, Gaskell E. Jean-Nicolas Marjolin: destined to be forgotten? Med Hist. 1963;7:383–4.PubMed
9.
Zurück zum Zitat Copcu E, Aktas A, Sisman N, Oztan Y. Thirty-one cases of Marjolin’s ulcer. Clin Exp Dermatol. 2003;28(2):138–41.PubMedCrossRef Copcu E, Aktas A, Sisman N, Oztan Y. Thirty-one cases of Marjolin’s ulcer. Clin Exp Dermatol. 2003;28(2):138–41.PubMedCrossRef
10.
Zurück zum Zitat Fleming MD, Hunt JL, Purdue GF, Sandstad J. Marjolin’s ulcer: a review and reevaluation of a difficult problem. J Burn Care Rehabil. 1990;11(5):460–9.PubMedCrossRef Fleming MD, Hunt JL, Purdue GF, Sandstad J. Marjolin’s ulcer: a review and reevaluation of a difficult problem. J Burn Care Rehabil. 1990;11(5):460–9.PubMedCrossRef
11.
Zurück zum Zitat Bauer T, David T, Rimareix F, Lortat-Jacob A. Marjolin’s ulcer in chronic osteomyelitis: seven cases and a review of the literature. Rev Chir Orthop Reparatrice Appar Mot. 2007;93(1):63–71.PubMedCrossRef Bauer T, David T, Rimareix F, Lortat-Jacob A. Marjolin’s ulcer in chronic osteomyelitis: seven cases and a review of the literature. Rev Chir Orthop Reparatrice Appar Mot. 2007;93(1):63–71.PubMedCrossRef
12.
Zurück zum Zitat Phillips TJ, Salman SM, Bhawan J, Rogers GS. Burn scar carcinoma. Diagnosis and management. Dermatol Surg. 1998;24(5):561–5.PubMedCrossRef Phillips TJ, Salman SM, Bhawan J, Rogers GS. Burn scar carcinoma. Diagnosis and management. Dermatol Surg. 1998;24(5):561–5.PubMedCrossRef
13.
Zurück zum Zitat Chiang KH, Chou AS, Hsu YH, Lee SK, Lee CC, Yen PS, et al. Marjolin’s ulcer: MR appearance. AJR Am J Roentgenol. 2006;186(3):819–20.PubMedCrossRef Chiang KH, Chou AS, Hsu YH, Lee SK, Lee CC, Yen PS, et al. Marjolin’s ulcer: MR appearance. AJR Am J Roentgenol. 2006;186(3):819–20.PubMedCrossRef
14.
Zurück zum Zitat Celikoz B, Demiriz M, Selmanpakoglu N. A shorter lag period of mesenchymal malignancy on Marjolin’s ulcer. Burns. 1997;23(1):72–4.PubMedCrossRef Celikoz B, Demiriz M, Selmanpakoglu N. A shorter lag period of mesenchymal malignancy on Marjolin’s ulcer. Burns. 1997;23(1):72–4.PubMedCrossRef
15.
Zurück zum Zitat Lee SH, Shin MS, Kim HS, Park WS, Kim SY, Jang JJ, et al. Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar. J Invest Dermatol. 2000;114(1):122–6.PubMedCrossRef Lee SH, Shin MS, Kim HS, Park WS, Kim SY, Jang JJ, et al. Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar. J Invest Dermatol. 2000;114(1):122–6.PubMedCrossRef
16.
Zurück zum Zitat Harland DL, Robinson WA, Franklin WA. Deletion of the p53 gene in a patient with aggressive burn scar carcinoma. J Trauma. 1997;42(1):104–7.PubMedCrossRef Harland DL, Robinson WA, Franklin WA. Deletion of the p53 gene in a patient with aggressive burn scar carcinoma. J Trauma. 1997;42(1):104–7.PubMedCrossRef
17.
Zurück zum Zitat Lifeso RM, Rooney RJ, el-Shaker M. Post-traumatic squamous-cell carcinoma. J Bone Joint Surg Am. 1990;72(1):12–8.PubMed Lifeso RM, Rooney RJ, el-Shaker M. Post-traumatic squamous-cell carcinoma. J Bone Joint Surg Am. 1990;72(1):12–8.PubMed
18.
Zurück zum Zitat Tank J, Scharschmidt T, Weiner SD. Development of bilateral lower extremity Marjolin ulcers after childhood burns. Am J Orthop (Belle Mead NJ). 2008;37(6):E113–5. Tank J, Scharschmidt T, Weiner SD. Development of bilateral lower extremity Marjolin ulcers after childhood burns. Am J Orthop (Belle Mead NJ). 2008;37(6):E113–5.
19.
Zurück zum Zitat Dupree MT, Boyer JD, Cobb MW. Marjolin’s ulcer arising in a burn scar. Cutis. 1998;62(1):49–51.PubMed Dupree MT, Boyer JD, Cobb MW. Marjolin’s ulcer arising in a burn scar. Cutis. 1998;62(1):49–51.PubMed
20.
Zurück zum Zitat Ryan RF, Litwin MS, Krementz ET. A new concept in the management of Marjolin’s ulcers. Ann Surg. 1981;193(5):598–605.PubMedCrossRef Ryan RF, Litwin MS, Krementz ET. A new concept in the management of Marjolin’s ulcers. Ann Surg. 1981;193(5):598–605.PubMedCrossRef
21.
Zurück zum Zitat Aydogdu E, Yildirim S, Akoz T. Is surgery an effective and adequate treatment in advanced Marjolin’s ulcer? Burns. 2005;31(4):421–31.PubMedCrossRef Aydogdu E, Yildirim S, Akoz T. Is surgery an effective and adequate treatment in advanced Marjolin’s ulcer? Burns. 2005;31(4):421–31.PubMedCrossRef
22.
Zurück zum Zitat Hammond JS, Thomsen S, Ward CG. Scar carcinoma arising acutely in a skin graft donor site. J Trauma. 1987;27(6):681–3.PubMedCrossRef Hammond JS, Thomsen S, Ward CG. Scar carcinoma arising acutely in a skin graft donor site. J Trauma. 1987;27(6):681–3.PubMedCrossRef
23.
Zurück zum Zitat Love RL, Breidahl AF. Acute squamous cell carcinoma arising within a recent burn scar in a 14-year-old boy. Plast Reconstr Surg. 2000;106(5):1069–71.PubMedCrossRef Love RL, Breidahl AF. Acute squamous cell carcinoma arising within a recent burn scar in a 14-year-old boy. Plast Reconstr Surg. 2000;106(5):1069–71.PubMedCrossRef
24.
Zurück zum Zitat Kannan RY, Rauf GK. Acute burn scar basal cell carcinoma. Ann Plast Surg. 2010;64(3):321–2.PubMedCrossRef Kannan RY, Rauf GK. Acute burn scar basal cell carcinoma. Ann Plast Surg. 2010;64(3):321–2.PubMedCrossRef
25.
Zurück zum Zitat Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26(1):79–83.PubMedCrossRef Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26(1):79–83.PubMedCrossRef
26.
Zurück zum Zitat Lopez ML, Lana A, Diaz S, Folgueras MV, Sanchez L, Comendador MA, et al. Multiple primary cancer: an increasing health problem. Strategies for prevention in cancer survivors. Eur J Cancer Care (Engl). 2009;18(6):598–605.CrossRef Lopez ML, Lana A, Diaz S, Folgueras MV, Sanchez L, Comendador MA, et al. Multiple primary cancer: an increasing health problem. Strategies for prevention in cancer survivors. Eur J Cancer Care (Engl). 2009;18(6):598–605.CrossRef
27.
Zurück zum Zitat Warren S, Gates O. Multiple primary malignant tumors; surgery of literature and statistical study. Am J Cancer. 1932;16(1):1358–414. Warren S, Gates O. Multiple primary malignant tumors; surgery of literature and statistical study. Am J Cancer. 1932;16(1):1358–414.
28.
Zurück zum Zitat Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. I. Introduction and presentation of data. Cancer. 1961;14:221–30.PubMedCrossRef Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. I. Introduction and presentation of data. Cancer. 1961;14:221–30.PubMedCrossRef
29.
Zurück zum Zitat Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. II. Tumors of different tissues or organs. Cancer. 1961;14:231–7.PubMedCrossRef Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. II. Tumors of different tissues or organs. Cancer. 1961;14:231–7.PubMedCrossRef
30.
Zurück zum Zitat Aguilo R, Macia F, Porta M, Casamitjana M, Minguella J, Novoa AM. Multiple independent primary cancers do not adversely affect survival of the lung cancer patient. Eur J Cardiothorac Surg. 2008;34(5):1075–80.PubMedCrossRef Aguilo R, Macia F, Porta M, Casamitjana M, Minguella J, Novoa AM. Multiple independent primary cancers do not adversely affect survival of the lung cancer patient. Eur J Cardiothorac Surg. 2008;34(5):1075–80.PubMedCrossRef
31.
Zurück zum Zitat Aydiner A, Karadeniz A, Uygun K, Tas S, Tas F, Disci R, et al. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms. Am J Clin Oncol. 2000;23(4):364–70.PubMedCrossRef Aydiner A, Karadeniz A, Uygun K, Tas S, Tas F, Disci R, et al. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms. Am J Clin Oncol. 2000;23(4):364–70.PubMedCrossRef
32.
Zurück zum Zitat Dacic S, Ionescu DN, Finkelstein S, Yousem SA. Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol. 2005;29(7):897–902.PubMedCrossRef Dacic S, Ionescu DN, Finkelstein S, Yousem SA. Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol. 2005;29(7):897–902.PubMedCrossRef
Metadaten
Titel
Development of Marjolin’s ulcer within one month of burn injury with synchronous primary lung squamous cell carcinoma in an elderly patient: report of a case with allelotyping
verfasst von
Adam N. Wooldridge
Michael J. Griesser
Thomas Scharschmidt
O. Hans Iwenofu
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe Sonderheft 1/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9744-4

Weitere Artikel der Sonderheft 1/2011

Medical Oncology 1/2011 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.